::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

COMPARATIVE EFFECT OF FIXED DOSE COMBINATION OF BISOPROLOL+ AMLODIPINE VERSUS BISOPROLOL AND AMLODIPINE ALONE ON BLOOD PRESSURE IN STAGE-2 ESSENTIAL HYPERTENSIVE PATIENTS

AUTHORS:

Dr. Muhammad Mashood, Dr. Maryam Shabbir, Dr. Zahoor Ahmed Khan

ABSTRACT:

Background: Employment of low dose combinations of two antihypertensives, with different mode of action has gained acceptance worldwide for the treatment of mild to moderate hypertension. However, most studies in hypertensive disease have focused on monotherapy. The combination therapy in the treatment of hypertension is largely extrapolated from these monotherapy studies. Objectives: To study and compare the effect of amlodipine, bisoprolol and fixed dose combination of amlodipine + bisoprolol on blood pressure in stage-2 essential hypertensive patients. Methods: The present study was carried out in Department of Pharmacology in collaboration with Department of Medicine at Mayo Hospital, Lahore for six months duration from October 2019 to March 2020. Results and Conclusion: Amlodipine + bisoprolol in fixed dose combination have showed significant blood pressure control in patients of stage-2 essential hypertension and the antihypertensive effect was greater than individual monotherapy study groups. Keywords: Amlodipine, Bisoprolol, Hypertension stage 2.